Skip to content

A clinical trial of MK-8210 in healthy participants (MK-8210-001)

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2026-527022-13-00
Enrollment
88
Registered
2026-08-19
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV-1 (Human Immunodeficiency Virus Type 1)

Interventions

None listed

Sponsors

Merck Sharp & Dohme LLC
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Outcome results

None listed

Source: EU CTIS · Data processed: Aug 20, 2026